Your browser doesn't support javascript.
loading
High Mortality of COVID-19 Early after Allogeneic Stem Cell Transplantation: A Retrospective Multicenter Analysis on Behalf of the German Cooperative Transplant Study Group.
Schaffrath, Judith; Brummer, Christina; Wolff, Daniel; Holtick, Udo; Kröger, Nicolaus; Bornhäuser, Martin; Kraus, Sabrina; Hilgendorf, Inken; Blau, Igor-Wolfgang; Penack, Olaf; Wittke, Christoph; Steiner, Normann; Nachbaur, David; Thurner, Lorenz; Hindahl, Heidrun; Zeiser, Robert; Maier, Claus-Philipp; Bethge, Wolfgang; Müller, Lutz P.
Afiliação
  • Schaffrath J; Department of Internal Medicine IV - Hematology and Oncology, Martin Luther University Halle-Wittenberg, Halle (Saale), Germany. Electronic address: judith.schaffrath@uk-halle.de.
  • Brummer C; Department of Internal Medicine III, University Hospital of Regensburg, Regensburg, Germany.
  • Wolff D; Department of Internal Medicine III, University Hospital of Regensburg, Regensburg, Germany.
  • Holtick U; Department I of Internal Medicine, University of Cologne, Faculty of Medicine and University Hospital, Cologne, Germany.
  • Kröger N; Department of Stem Cell Transplantation, University Hospital Hamburg-Eppendorf, Hamburg, Germany.
  • Bornhäuser M; Department of Internal Medicine I, University Hospital Carl Gustav Carus, TU Dresden, Dresden, Germany.
  • Kraus S; Department of Internal Medicine II, University Hospital of Würzburg, Würzburg, Germany.
  • Hilgendorf I; Department of Internal Medicine II, University Hospital of Jena, Jena, Germany.
  • Blau IW; Department of Hematology, Oncology and Tumorimmunology, Charité-Universitätsmedizin Berlin, corporate member of Freie Universität Berlin and Humboldt-Universität zu Berlin, Berlin, Germany.
  • Penack O; Department of Hematology, Oncology and Tumorimmunology, Charité-Universitätsmedizin Berlin, corporate member of Freie Universität Berlin and Humboldt-Universität zu Berlin, Berlin, Germany.
  • Wittke C; Department of Internal Medicine III, University Hospital of Rostock, Rostock, Germany.
  • Steiner N; University Hospital of Internal Medicine V, Innsbruck Medical University, Innsbruck, Austria.
  • Nachbaur D; University Hospital of Internal Medicine V, Innsbruck Medical University, Innsbruck, Austria.
  • Thurner L; Department of Internal Medicine I, Saarland University, Homburg, Germany.
  • Hindahl H; Department of Internal Medicine II, St.-Johannes-Hospital Dortmund, Dortmund, Germany.
  • Zeiser R; Department of Internal Medicine I, Medical Center - University of Freiburg, Faculty of Medicine, Freiburg, Germany.
  • Maier CP; Department of Hematology, Oncology, Clinical Immunology and Rheumatology, University Hospital Tuebingen, Tuebingen, Germany.
  • Bethge W; Department of Hematology, Oncology, Clinical Immunology and Rheumatology, University Hospital Tuebingen, Tuebingen, Germany.
  • Müller LP; Department of Internal Medicine IV - Hematology and Oncology, Martin Luther University Halle-Wittenberg, Halle (Saale), Germany.
Transplant Cell Ther ; 28(6): 337.e1-337.e10, 2022 06.
Article em En | MEDLINE | ID: mdl-35296445
Assuntos
Palavras-chave
Texto completo
Adicionar na Minha BVS
Imprimir
XML
PubMed Links
Buscar no Google

Texto completo: 1 Bases de dados: MEDLINE Assunto principal: Transplante de Células-Tronco Hematopoéticas / COVID-19 Tipo de estudo: Observational_studies / Risk_factors_studies Limite: Adult / Aged / Aged80 / Humans / Middle aged Idioma: En Revista: Transplant Cell Ther Ano de publicação: 2022 Tipo de documento: Article
Texto completo
Adicionar na Minha BVS
Imprimir
XML
PubMed Links
Buscar no Google

Texto completo: 1 Bases de dados: MEDLINE Assunto principal: Transplante de Células-Tronco Hematopoéticas / COVID-19 Tipo de estudo: Observational_studies / Risk_factors_studies Limite: Adult / Aged / Aged80 / Humans / Middle aged Idioma: En Revista: Transplant Cell Ther Ano de publicação: 2022 Tipo de documento: Article